DNA Vaccines
Studies from National Institute of Allergy and Infectious Disease in the area of DNA vaccines described
Published in AIDS Weekly and Law, May 10th, 2007
A new study, "Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects," is now available. Researchers in the United States conducted a study "To evaluate the safety and immunogenicity of a candidate HIV DNA vaccine administered using a needle-free device. In this phase 1, dose escalation, double-blind, placebo-controlled clinical trial, 21 healthy adults were randomized to receive placebo or 0.5, 1.5, or 4 mg of a single plasmid expressing a Gag/Pol fusion protein."
"Each participant received repeat immunizations at days 28 and 56 after the first inoculation. Safety and immunogenicity data...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly and Law
Source: AIDS Weekly and Law (2007-05-10)
More Articles from AIDS Weekly and Law
- HIV/AIDS
Senator Jeff Sessions Recognized at the National Leadership Summit on Health Disparities - DNA Vaccines
VGX Pharmaceuticals Announces DNA Vaccines License Agreement with University of Pennsylvania - HIV/AIDS
Abbott Continues Drug Blacklist in Thailand, Says AIDS Healthcare Foundation - HIV/AIDS
ADVENTRX ANX-201 Abstract Accepted for Presentation at International AIDS Conference - HIV/AIDS
amfAR's Trek Africa Will Educate Participants About the Reality of AIDS In Sub-Saharan Africa - HIV/AIDS
Data on HIV/AIDS detailed by researchers at University of Washington, Department of Medicine - More from this issue of AIDS Weekly and Law
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
